Back to Search
Start Over
Weight change and atypical antipsychotic treatment in patients with schizophrenia.
- Source :
-
The Journal of clinical psychiatry [J Clin Psychiatry] 2001; Vol. 62 Suppl 2, pp. 41-4. - Publication Year :
- 2001
-
Abstract
- Schizophrenic patients who have been prescribed atypical antipsychotics have a potential risk of gaining weight. The implications of weight gain for clinical care may differ depending on whether a patient is underweight or overweight at baseline. The exact mechanism for weight gain is not known, but several factors have been identified that can help predict which patients are at risk for gaining weight. These factors include better clinical outcome, increased appetite, and low baseline body mass index. In patients treated with olanzapine for up to 3 years, weight gain trended toward a plateau at approximately 36 weeks. Weight gain interventions, including behavioral modifications, show promise in controlling or reducing weight in patients treated with antipsychotics.
- Subjects :
- Antipsychotic Agents administration & dosage
Antipsychotic Agents therapeutic use
Behavior Therapy methods
Benzodiazepines
Dose-Response Relationship, Drug
Follow-Up Studies
Haloperidol administration & dosage
Haloperidol adverse effects
Haloperidol therapeutic use
Health Behavior
Humans
Obesity chemically induced
Obesity prevention & control
Olanzapine
Pirenzepine administration & dosage
Pirenzepine therapeutic use
Risperidone administration & dosage
Risperidone adverse effects
Risperidone therapeutic use
Antipsychotic Agents adverse effects
Pirenzepine adverse effects
Pirenzepine analogs & derivatives
Schizophrenia drug therapy
Weight Gain drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 0160-6689
- Volume :
- 62 Suppl 2
- Database :
- MEDLINE
- Journal :
- The Journal of clinical psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 11232752